AXON
Price
$780.63
Change
+$5.43 (+0.70%)
Updated
Jun 13 closing price
Capitalization
60.77B
58 days until earnings call
LGND
Price
$112.50
Change
-$1.95 (-1.70%)
Updated
Jun 13 closing price
Capitalization
2.17B
57 days until earnings call
Interact to see
Advertisement

AXON vs LGND

Header iconAXON vs LGND Comparison
Open Charts AXON vs LGNDBanner chart's image
Axon Enterprise
Price$780.63
Change+$5.43 (+0.70%)
Volume$359.1K
Capitalization60.77B
Ligand Pharmaceuticals
Price$112.50
Change-$1.95 (-1.70%)
Volume$83.34K
Capitalization2.17B
AXON vs LGND Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. LGND commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and LGND is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (AXON: $780.63 vs. LGND: $112.50)
Brand notoriety: AXON and LGND are both not notable
AXON represents the Aerospace & Defense, while LGND is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 65% vs. LGND: 75%
Market capitalization -- AXON: $60.77B vs. LGND: $2.17B
AXON [@Aerospace & Defense] is valued at $60.77B. LGND’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $252.31B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $19.54B. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 3 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 3 green, 2 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 2 TA indicator(s) are bullish while LGND’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 2 bullish, 5 bearish.
  • LGND’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LGND is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а -1.42% price change this week, while LGND (@Biotechnology) price change was +6.14% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +0.96%. For the same industry, the average monthly price growth was +16.28%, and the average quarterly price growth was +33.28%.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

AXON is expected to report earnings on Aug 12, 2025.

LGND is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Aerospace & Defense (+0.96% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($60.8B) has a higher market cap than LGND($2.17B). AXON has higher P/E ratio than LGND: AXON (188.10) vs LGND (46.19). AXON YTD gains are higher at: 31.348 vs. LGND (4.993). AXON has higher annual earnings (EBITDA): 398M vs. LGND (-122.1M). AXON has more cash in the bank: 2.37B vs. LGND (209M). LGND has less debt than AXON: LGND (4.45M) vs AXON (2.05B). AXON has higher revenues than LGND: AXON (2.23B) vs LGND (181M).
AXONLGNDAXON / LGND
Capitalization60.8B2.17B2,801%
EBITDA398M-122.1M-326%
Gain YTD31.3484.993628%
P/E Ratio188.1046.19407%
Revenue2.23B181M1,230%
Total Cash2.37B209M1,133%
Total Debt2.05B4.45M46,021%
FUNDAMENTALS RATINGS
AXON vs LGND: Fundamental Ratings
AXON
LGND
OUTLOOK RATING
1..100
3838
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
758
SMR RATING
1..100
5392
PRICE GROWTH RATING
1..100
147
P/E GROWTH RATING
1..100
892
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LGND's Valuation (76) in the Biotechnology industry is in the same range as AXON (99). This means that LGND’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (7) in the Biotechnology industry is somewhat better than the same rating for LGND (58). This means that AXON’s stock grew somewhat faster than LGND’s over the last 12 months.

AXON's SMR Rating (53) in the Biotechnology industry is somewhat better than the same rating for LGND (92). This means that AXON’s stock grew somewhat faster than LGND’s over the last 12 months.

AXON's Price Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for LGND (47). This means that AXON’s stock grew somewhat faster than LGND’s over the last 12 months.

AXON's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for LGND (92). This means that AXON’s stock grew significantly faster than LGND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONLGND
RSI
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DENN4.130.09
+2.23%
Denny's Corp
ERIE356.76-2.00
-0.56%
Erie Indemnity Company
SLG65.20-0.55
-0.84%
SL Green Realty Corp
MNRO14.61-1.04
-6.65%
Monro
XFOR2.82-0.23
-7.54%
X4 Pharmaceuticals Inc

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+0.70%
TECH - AXON
61%
Loosely correlated
-1.96%
VCYT - AXON
58%
Loosely correlated
-0.94%
BEAM - AXON
57%
Loosely correlated
-2.18%
SEER - AXON
56%
Loosely correlated
-2.82%
ADPT - AXON
56%
Loosely correlated
-0.86%
More